SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-000007
Filing Date
2017-01-03
Accepted
2017-01-03 08:00:23
Documents
3
Period of Report
2017-01-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k010317_biondvaxpharma.htm 6-K 29254
2 PRESS RELEASE, DATED JANUARY 2, 2017 f6k010317ex99i_biondvax.htm EX-99.1 12142
3 GRAPHIC ex99i_01.jpg GRAPHIC 18637
  Complete submission text file 0001213900-17-000007.txt   68195
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 17500370
SIC: 2836 Biological Products, (No Diagnostic Substances)